Markets & Regulations

Inyx acquires CMSL from UCB

Inyx acquires CMSL from UCB

By Wai Lang Chu

Drug delivery specialists, Inyx has announced the acquisition of
Celltech Manufacturing Services from biopharmaceutical company UCB
for €27.5 million (€22.3 million). The acquisition adds to Inyx's
recently established operating...

Sun Pharma buys Hungarian plant

Sun Pharma buys Hungarian plant

By Phil Taylor

Sun Pharmaceutical Industries has become the second Indian
drugmaker in a matter of days to announce the purchase of a
manufacturing facility in Eastern Europe that will serve as a
springboard for expansion into the broader European...